OVARIAN CANCER RECURRENT
Clinical trials for OVARIAN CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER RECURRENT trials appear
Sign up with your email to follow new studies for OVARIAN CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat ovarian and endometrial cancers
Disease control Not yet recruitingThis early-phase trial tests a one-time treatment called OPB-201, where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells that carry a protein called PRAME. The study will enroll 30 adults with recurrent endometrial cancer or platinum-…
Matched conditions: OVARIAN CANCER RECURRENT
Phase: PHASE1 • Sponsor: Outpace Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can surgery buy more time for ovarian cancer patients?
Disease control Not yet recruitingThis study looks at whether a second surgery to remove visible tumors (secondary cytoreductive surgery) after chemotherapy helps women with platinum-sensitive recurrent ovarian cancer. About 160 participants will be randomly assigned to get surgery plus chemo or chemo alone. The …
Matched conditions: OVARIAN CANCER RECURRENT
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC